Discovering new drugs is a complicated, time-consuming, costly, risky and failure-prone process. However, about 80% of the drugs that have been approved so far are targeted at protein targets, and 99% ...
Large language models (LLMs) can be broadly applied across multiple key stages in drug development: (1) Target identification and drug screening. Llama-Gram, GPCR LLM, and ProtChat systems effectively ...
Smart multi-target drugs are reshaping modern therapeutics by addressing the complex, interconnected pathways that drive diseases like Alzheimer’s, cancer, and major depressive disorder. Advances in ...